Your body clears alcohol in two steps. First an enzyme turns the ethanol into acetaldehyde — toxic and reactive. Then ALDH2 turns the acetaldehyde into harmless acetate. Carry the broken version of ALDH2, a single typo in the gene called rs671, and the second step stalls: the acetaldehyde pools in your blood for hours instead of clearing in minutes. That's the flush.
About one in three Han Chinese, Japanese, and Korean adults carries it, roughly 540 million people 1. One broken piece poisons the whole enzyme, so heterozygotes keep under 20% of normal function, not half 2.
A heterozygous carrier who drinks like a non-carrier runs about three times the odds of esophageal cancer 3, and the same pattern holds for the larynx, throat, and mouth 4. Here's the twist that matters: people with two broken copies have lower cancer rates than carriers with one 3. The reaction is so violent they never become drinkers. The risk lands on the people in the middle, the ones who can push through the flush and keep going for decades.
Screen yourself before you decide anything. Two questions read about as well as the gene test 5:
What quitting buys a carrier, over time:
- Weeks: the Sunday-after headache and racing half-sleep you read as "I just don't tolerate alcohol" stop, because the acetaldehyde load is gone.
- Social: "I get cancer risk from it" buys real permission that "not drinking these days" doesn't, especially where drinking is woven into work.
- Years: the esophageal-cancer odds fall back toward a non-carrier's, gradually, since cumulative exposure is what counted 2.
The fine print — when to skip it, and what people get wrong
A fading flush isn't tolerance: the histamine response quiets while the enzyme stays broken and the carcinogen still pools 2. And it isn't only East Asian; related variants appear in South Asian and other populations 1.
Famotidine (Pepcid) and antihistamines hide the flush but not the acetaldehyde still pooling in your throat, so masking it only lets you drink more 6. Carriers needing sublingual nitroglycerin should tell the doctor; it works less well in them 7.
- 1Chen CH, Ferreira JCB, Gross ER, Mochly-Rosen D (2014). Targeting Aldehyde Dehydrogenase 2: New Therapeutic Opportunities. Physiological Reviews. link
- 2Brooks PJ, Enoch M-A, Goldman D, Li T-K, Yokoyama A (2009). The Alcohol Flushing Response: An Unrecognized Risk Factor for Esophageal Cancer from Alcohol Consumption. PLoS Medicine. link
- 3Lewis SJ, Smith GD (2005). Alcohol, ALDH2, and esophageal cancer: a meta-analysis which illustrates the potentials and limitations of a Mendelian randomization approach. Cancer Epidemiology, Biomarkers and Prevention. link
- 4Boccia S, Hashibe M, Galli P, De Feo E, Asakage T, Hashimoto T, Hiraki A, Katoh T, Nomura T, Yokoyama A, van Duijn CM, Ricciardi G, Boffetta P (2009). Aldehyde Dehydrogenase 2 and Head and Neck Cancer: A Meta-analysis Implementing a Mendelian Randomization Approach. Cancer Epidemiology, Biomarkers and Prevention. link
- 5Yokoyama T, Yokoyama A, Kato H, Tsujinaka T, Muto M, Omori T, Haneda T, Kumagai Y, Igaki H, Yokoyama M, Watanabe H, Yoshimizu H (2003). Alcohol Flushing, Alcohol and Aldehyde Dehydrogenase Genotypes, and Risk for Esophageal Squamous Cell Carcinoma in Japanese Men. Cancer Epidemiology, Biomarkers and Prevention. link
- 6University of Southern California Keck School of Medicine (2020). Antihistamines prevent 'Asian flush' but with huge risks. link
- 7Gross ER, Zambelli VO, Small BA, Ferreira JCB, Chen CH, Mochly-Rosen D (2015). A personalized medicine approach for Asian Americans with the aldehyde dehydrogenase 2*2 variant. Annual Review of Pharmacology and Toxicology. link
დაკავშირებული სახელმძღვანელოში (3)
- — This flush gene is exactly why alcohol's carcinogen risk hits some people much harder.
- — A genetic test confirms the flush gene if the two-question check leaves you unsure.
- — Both stack the same esophageal-cancer risk — if you carry the flush gene, also skip scalding drinks.